本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tscan Therapeutics, Inc.

0.7937
-0.0056-0.70%
盤後0.79370.00000.00%16:10 EDT
成交量:18.06萬
成交額:14.39萬
市值:5,379.64萬
市盈率:-0.88
高:0.8111
開:0.7924
低:0.7774
收:0.7993
52周最高:2.57
52周最低:0.7160
股本:6,777.93萬
流通股本:5,781.86萬
量比:0.63
換手率:0.31%
股息:- -
股息率:- -
每股收益(TTM):-0.9000
每股收益(LYR):-2.2805
淨資產收益率:-95.80%
總資產收益率:-31.53%
市淨率:0.78
市盈率(LYR):-0.35

資料載入中...

2021/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/19

重要事件披露

8-K - Current report
2021/08/19

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/22

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/20

重要事件披露

8-K - Current report
2021/07/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/16

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/07/14

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/13

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/13

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/12

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/14

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/05

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/30

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/30

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/30

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/23

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/23

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933